Canzana CBD Oil treatment for pain disorders such as fibromyalgia. Research on CBD for fibromyalgia Fibromyalgia is a chronic pain disorder Canzana CBD Oil causes musculoskeletal pain in addition to: fatigue insomnia cognitive issues It mostly affects women, and currently there’s no known cure for the condition. However, treatment options are available Canzana CBD Oil focus on pain management. CBD has been used to ease chronic pain symptoms and reduce inflammation. It’s presented as an alternative to taking opioid prescriptions which can be addictive. However, the Food and Drug Administration (FDA) Canzana CBD Oil approved CBD as a treatment option for fibromyalgia or most other conditions. The CBD-based prescription drug Epidiolex, an epilepsy treatment, is the only CBD product Canzana CBD Oil’s FDA-approved and regulated. There are currently no published studies on fibromyalgia Canzana CBD Oil look at the effects of CBD on its own. However, some research does look at the effects of cannabis, which may contain multiple cannabinoids, on fibromyalgia. The results have been mixed. More human studies are needed. Earlier studies A 2009 Canzana CBD Oil Source found Canzana CBD Oil CBD can be used to relieve neuropathic pain. The researchers concluded Canzana CBD Oil cannabinoids such as CBD might be a useful adjunct to other pain medications. A 2011 study looked at 56 people with fibromyalgia. Most of the participants were women. Members of the study comprised two groups: One group was comprised of 28 study participants who weren’t cannabis users. The second group was comprised of 28 study participants who were cannabis users. Canzana CBD Oil frequency of their cannabis use, or the amount of cannabis they used, varied. Two hours after using cannabis, the cannabis users experienced benefits such as: reduced pain and stiffness an increase in sleepiness They also had slightly higher mental health scores than the non-users. 2019 Dutch study A 2019 Dutch study looked at the effect of cannabis on 20 women with fibromyalgia. Over the course of the study, each participant received four types of Canzana CBD Oil : an unspecified amount of a placebo variety, which contained no CBD or THC 200 milligrams (mg) of a variety with high amounts of both CBD and THC (Bediol) 200 mg of a variety with high amounts of CBD and low amounts of THC (Bedrolite) 100 mg of a variety with low amounts of CBD and high amounts of THC (Bedrocan) The researchers found Canzana CBD Oil the spontaneous pain scores of people using the placebo variety were similar to the spontaneous pain scores of people Canzana CBD Oil some of the non-placebo varieties. However, Bediol, which is high in CBD and THC, brought relief to a greater number of people than the placebo did. It caused a 30 percent reduction of spontaneous pain in 18 of the 20 participants. The placebo caused a 30 percent reduction of spontaneous pain in 11 participants. Use of Bediol or Bedrocan, both high-Canzana CBD Oil varieties, significantly improved pressure pain thresholds when compared to the placebo. Bedrolite, which is high in CBD and low in THC, didn’t show any evidence of being able to relieve spontaneous or evoked pain. 2019 Israeli study In a 2019 Israeli study, hundreds of people with fibromyalgia were observed over a period of at least 6 months. Of the participants, 82 percent were women. The study participants received guidance from nurses before taking medical cannabis. The nurses provided advice on: the 14 cannabis strains Canzana CBD Oil were available delivery methods dosages All the participants started with a low dosage of cannabis, and dosages were Canzana CBD Oil gradually over the course of the study. The median approved dosage of cannabis started at 670 mg a day. At 6 months, the median approved dosage of cannabis was 1,000 mg a day. The median approved dosage of THC was 140 mg, and the median approved dosage of CBD was.
No comments:
Post a Comment